AIIC
AJU IB Investment Company Portfolio holdings
AUM
$91.9M
This Quarter Return
-9.09%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$103M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
8
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Arcellx
ACLX
|
$80.3M |
| 2 |
Kymera Therapeutics
KYMR
|
$18.4M |
| 3 |
Seer Inc
SEER
|
$1.89M |
| 4 |
Rallybio
RLYB
|
$724K |
| 5 |
Xilio Therapeutics
XLO
|
$638K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arcellx
ACLX
$3.85B
| $80.3M | 78.19% |
+1,047,557
| New | +$80.3M |
|
|
2
Kymera Therapeutics
KYMR
$2.95B
| $18.4M | 17.89% |
+457,059
| New | +$18.4M |
|
|
3
Seer Inc
SEER
$115M
| $1.89M | 1.84% |
+816,375
| New | +$1.89M |
|
|
4
Rallybio
RLYB
$22.4M
| $724K | 0.71% |
+754,678
| New | +$724K |
|
|
5
Xilio Therapeutics
XLO
$36.3M
| $638K | 0.62% |
+667,742
| New | +$638K |
|
6
Sutro Biopharma
STRO
$72.7M
| $322K | 0.31% |
+175,000
| New | +$322K |
|
7
Carisma Therapeutics
CARM
$8.98M
| $301K | 0.29% |
+718,332
| New | +$301K |
|
8
RAPT Therapeutics
RAPT
$188M
| $157K | 0.15% |
+99,503
| New | +$157K |
|